Empowering clinicians with AI medical technologies that solve real challenges.
About Us
Keya Medical is redefining how clinicians evaluate and manage coronary artery disease through advanced artificial intelligence and data-driven imaging analysis.
Keya Medical is an international medical technology company specializing in deep learning-based solutions for cardiovascular diagnosis. Its flagship product, DEEPVESSEL FFR, is an FDA-cleared, CE-marked, NMPA-approved, and certified by HSA of Singapore CT-FFR analysis that provides non-invasive coronary artery assessment using CCTA.
Headquartered in Seattle, Washington, and Shenzhen, China, Keya Medical operates across Asia, Europe, and North America. Our solutions are supported by regulatory approvals, including FDA 510(k) clearance, CE Mark, and NMPA certification, with deployments in leading hospitals and imaging centers worldwide. Keya Medical has been featured at international cardiovascular and imaging conferences, including SCCT, ECR, and RSNA.
To learn more about Keya Medical, follow us on LinkedIn, Twitter, and Facebook.
Our Team
Letter from Mary-Pierre Waiss, President, North America
Welcome to Keya Medical.
Here, we believe that behind every scan, every diagnosis, and every innovation is a person — someone’s parent, child, or friend. That’s why our team is dedicated to combining cutting-edge deep learning technology with a deep sense of care.
Our presence in the United States continues to grow, and we are building a talented team committed to supporting clinicians, advancing research, and strengthening our partnerships across the cardiovascular community. Our advanced CCTA analysis tools are designed to help clinicians work faster and with greater accuracy.
Together, we’re shaping a future where heart health is stronger and patients’ outcomes are better.
Mary-Pierre Waiss – President, Keya Medical

Mary-Pierre Waiss
President, North America
Mary Waiss is a seasoned leader in biotechnology and healthcare technology with deep experience advancing innovation in patient care. She has held leadership and board positions at leading organizations including Keya Medical, Evergreen Bioscience Innovation Cluster, Precision Image Analysis, VentriPoint Diagnostics, and Boston Children’s Hospital, part of the Harvard Medical School system. She is dedicated to driving progress in cardiovascular imaging and improving care for patients with cardiovascular disease.

Matt Dichard
Sales Director, Northeast Region

Chad Thomas
Sales Director, Central Region

Mitch McCahey
Sales Director, West Region
Mitch McCahey is a veteran commercial sales and leadership executive with more than 30 years in cardiovascular medical devices at Boston Scientific, JNJ, Terumo, Medtronic, and Abbott. From 2019–2023, he helped lead HeartFlow’s CT-FFR adoption in the Pacific NW, establishing programs at Kaiser, Providence, Sutter, and the UC system, with his territory among the first to reach profitability. Mitch brings deep expertise in invasive and non-invasive FFR and strong knowledge of the U.S. cardiology and radiology markets.
Medical Advisors

John Rumberger, PhD, MD, FACC, MSCCT
Medical Director, Corazon Imaging
Dr. Rumberger is an accomplished medical professional and currently serves as the Medical Director at Corazon Imaging. His distinguished career includes serving as the Director of Cardiovascular Imaging at Princeton Longevity Center in New Jersey and as a former Professor of Medicine at the renowned Mayo Clinic. With his extensive fellowship in cardiology and an impressive portfolio of nearly 500 publications, he has made significant contributions to the field.

Irfan Shafique, MD
President, Forward Healthcare Consultans
Dr. Irfan Shafique is a renowned radiologist with extensive expertise in cardiac imaging. He is currently with Chesapeake Medical Imaging, overseeing the Cardiac Imaging program. Dr. Shafique is one of the pioneers of cardiac CTA imaging and training programs and courses at Johns Hopkins Bayview Medical Center. He is a former Johns Hopkins faculty member and co-directed the cardiac CT training practicum, and he continues to teach the CME course.

Intended for the U.S. market only. Not for EU promotional use.



